China approves use of Pfizer’s COVID drug Paxlovid
Coronavirus disease (COVID-19) treatment pill Paxlovid is seen in a box, at Misericordia hospital in Grosseto, Italy, February 8, 2022. REUTERS/Jennifer Lorenzini Register now for FREE unlimited access to Reuters.com Register BEIJING, Feb 12 (Reuters) – China’s medical products regulator said on Saturday it has given conditional approval for Pfizer’s (PFE.N) COVID-19 drug Paxlovid, making … Read more